Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients

In this study, we evaluated markers of apoptosis (active/cleaved caspase-3) and autophagy (LC3B) to establish whether these markers are useful prognostic indicators following neoadjuvant therapy.